For example, several CD248-specific antibodies have been recently developed for tumor therapy, including monoclonal antibodies such as MORAb-004, hMP-E−8.3, and 3K2L, as well as single-chain variable fragments (scFv) such as scFv78, scFv78-Fc (Li et al., 2014), scFv-CM6, scFv-1C1m, and scFv-7G22. This evidence concerns the gene IMMT and neoplasm.